Drugs / GSK4381406
last change Dec 2024 re-read 2 minutes ago

GSK4381406

Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05999708 Oct 2023 → Dec 2024 ulcerative colitis GlaxoSmithKline Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK4381406 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05999708